NEW YORK (GenomeWeb) – Sigma-Aldrich said today it will acquire Olink Bioscience's Duolink product portfolio.

Based on Olink's proximity ligation assay (PLA) technology, Duolink allows for detection of low-abundance proteins with higher specificity than conventional immunoassays.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.